Oscar Health Inc (NYSE:OSCR) finished Friday with an addition of $0.03 to close at $5.57, an upside of 0.54 percent. An average of 1,203,660 shares of common stock have been traded in the last five days. There was a gain of $0.02 in the past week, and it reached a new high 18 times over the past 12 months. The last 20 days have seen an average of 1,708,065 shares traded, while the 50-day average volume stands at 1,640,794.
OSCR stock has decreased by -12.28% in the last month. The company shares reached their 1-month lowest point of $5.31 on 09/25/23. With the stock rallying to its 52-week high on 06/13/23, shares of the company touched a low of $2.05 and a high of $9.89 in 52 weeks. It has reached a new high 34 times so far this year and achieved 126.42% or $3.11 in price. In spite of this, the price is down -43.68% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
OSCR stock investors should be aware that Oscar Health Inc (OSCR) stock had its last reported insider trading activity 24 days ago on Sep 06. In this transaction, the insider spent $188,311. EVP, Chief Insurance Officer, Quane Alessandrea C., disposed of 16,793 shares at a price of $6.26 on Sep 06. The insider now owns more than $105,196 worth of shares. Prior to that, Director Sankaran Sid went on to Sale 139,635 shares at $6.25 each on Sep 05. An amount of $872,719 was transacted.
Valuation Metrics
Oscar Health Inc (OSCR) stock’s beta is 1.10. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.24, the price-to-book (PB) ratio at 1.30, and the price-to-cash flow ratio at 7.92.
Financial Health
Further, the company has a long term debt to equity ratio of 0.31 and a total debt to equity ratio of 0.31 for the quarter ending June 29. Its gross profit as reported stood at -$610.08 million compared to revenue of $3.96 billion.
Earnings Surprise
For the three-month period that ended June 29, Oscar Health Inc had $298.39 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$15.53 million in the quarter, while revenues of -$39.77 million were shrunk -622.22%. The analyst consensus anticipated Oscar Health Inc’s latest quarter earnings to come in at -$0.23 per share, but it turned out to be -$0.07, a 69.60% surprise. For the quarter, EBITDA amounted to -$5.46 million. At the end of the quarter ending June 29, Oscar Health Inc’s stock balance sheet showed total debt was $368.66 million. Shareholders own equity worth $221.91 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Oscar Health Inc (OSCR) price momentum. RSI 9-day as of the close on 29 September was 30.02%, suggesting the stock is Neutral, with historical volatility in this time frame at 29.93%.
As of today, OSCR’s price is $5.52 +0.36% or $0.02 from its 5-day moving average. OSCR is currently trading -11.16% lower than its 20-day SMA and -25.93% lower than its 100-day SMA. However, the stock’s current price level is -32.73% below the SMA50 and +107.06% above the SMA200.
The stochastic %K and %D were 14.83% and 12.80%, respectively, and the average true range (ATR) was 0.26. With the 14-day stochastic at 18.91% and the average true range at 0.29, the RSI (14) stands at 32.03%. The stock has reached -0.14 on the 9-day MACD Oscillator while the 14-day reading was at -0.35.
Analyst Ratings
BofA Securities upgraded Oscar Health Inc (NYSE: OSCR) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as an Underperform.
